This week's View focuses on arrhythmia, with reviews of three articles having to do with a self-applied wearable electrocardiogram patch for detecting atrial fibrillation (AF), nonsteroidal anti-inflammatory drug use in patients taking dabigatran for AF, and the clinical validity of genes tested for Brugada syndrome.

Subscribe on iTunes | Subscribe on Google Play

Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, Cardiovascular Care Team, Geriatric Cardiology, Prevention, Anticoagulation Management and Atrial Fibrillation, Implantable Devices, Genetic Arrhythmic Conditions, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias

Keywords: EaglesEyeView, Anticoagulants, Arrhythmias, Cardiac, Atrial Fibrillation, Electrocardiography, Emergency Service, Hospital, Monitoring, Ambulatory, Primary Health Care, Primary Prevention, Risk Assessment, Stroke, Telemedicine, Vascular Diseases, Anti-Inflammatory Agents, Non-Steroidal, Brain Ischemia, Embolism, Gastrointestinal Hemorrhage, Geriatrics, Hemorrhage, Myocardial Infarction, Secondary Prevention, Stroke, Warfarin, Brugada Syndrome, Consensus, Death, Sudden, Death, Sudden, Cardiac, Genetic Testing, Phenotype, Anticoagulants

< Back to Listings